One of the more potent inhibitors of prostate cancer development, growth, and invasion is silibinin (silymarin compound).

It has been shown to increase the ability of doxorubicin to kill both androgen-dependent and -independent prostate cancer cells.

Doxorubicin is a very toxic chemotherapy drug. Combining it with silibinin allows a lower and therefore safer dose without diminishing its ability to kill prostate cancer cells.

Silibinin is quite safe, even in larger doses. It has the added advantage of protecting the liver, which can be damaged by many chemotherapy agents.

A final example of the anticancer synergy of natural plant extracts can be found in pomegranates. Several studies have shown that pomegranate extract can inhibit prostate cancer.

And when it is combined with quercetin and resveratrol, it inhibits leukemia cells.

It’s believed that the active component in pomegranate is ellagic acid, which can also be purchased as a pure natural supplement.

It is becoming obvious that complex mixtures of whole herbs and plant extracts, when properly compounded, can control even advanced cancers.

One such anticancer mixture was originally made by a Canadian nurse named Rene Caisse. It is now sold as Essiac tea (her last name spelled backward) with ingredients that include:

• Burdock root

• Sheep sorrel

• Slippery elm bark

• Turkish rhubarb

• Blessed thistle herb

• Organic red clover blossom

All of those plant extracts contain high concentrations of vitamins, minerals, flavonoids, proanthocyanidins, and other anticancer compounds, giving Essiac tea powerful anticancer synergy.

The tea has been shown to provide long-term control of some advanced cancers.

In addition, plant extracts have shown considerable safety and effectiveness.

By enhancing the cancer-killing and -suppressing ability of chemotherapy drugs and radiation treatments, they not only make those treatments more effective, they also make them safer by protecting normal cells and organs from damage caused by conventional treatments.

Yet I still have patients say that their oncologist told them to avoid these compounds because they “may interfere with their treatment.”

This lack of familiarity with modern medicalliterature is inexcusable in any doctor — and is costing many cancer patients their lives.